301 related articles for article (PubMed ID: 29904968)
1. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial.
Guzman AK; Schairer DO; Garelik JL; Cohen SR
Int J Dermatol; 2018 Aug; 57(8):1001-1006. PubMed ID: 29904968
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials.
Eichenfield LF; McFalda W; Brabec B; Siegfried E; Kwong P; McBride M; Rieger J; Willson C; Davidson M; Burnett P
JAMA Dermatol; 2020 Dec; 156(12):1315-1323. PubMed ID: 32965495
[TBL] [Abstract][Full Text] [Related]
3. A Phase 2 Open-Label Study to Evaluate VP-102 for the Treatment of Molluscum Contagiosum.
Niazi S; Brabec B; Anschutz L; Willson C; Davidson M; Burnett P
J Drugs Dermatol; 2021 Jan; 20(1):70-75. PubMed ID: 33400412
[TBL] [Abstract][Full Text] [Related]
4. Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial.
Coloe Dosal J; Stewart PW; Lin JA; Williams CS; Morrell DS
Pediatr Dermatol; 2014; 31(4):440-9. PubMed ID: 22897595
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Topical Cantharidin Treatment for Molluscum Contagiosum and Warts: A Systematic Review.
Vakharia PP; Chopra R; Silverberg NB; Silverberg JI
Am J Clin Dermatol; 2018 Dec; 19(6):791-803. PubMed ID: 30097988
[TBL] [Abstract][Full Text] [Related]
6. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum.
Eichenfield LF; Siegfried E; Kwong P; McBride M; Rieger J; Glover D; Willson C; Davidson M; Burnett P; Olivadoti M
Am J Clin Dermatol; 2021 Mar; 22(2):257-265. PubMed ID: 33599960
[TBL] [Abstract][Full Text] [Related]
7. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients.
Silverberg NB; Sidbury R; Mancini AJ
J Am Acad Dermatol; 2000 Sep; 43(3):503-7. PubMed ID: 10954663
[TBL] [Abstract][Full Text] [Related]
8. Cantharidin therapy for molluscum contagiosum in children.
Epstein E
J Am Acad Dermatol; 2001 Oct; 45(4):638. PubMed ID: 11568766
[No Abstract] [Full Text] [Related]
9. Cantharidin use among pediatric dermatologists in the treatment of molluscum contagiosum.
Coloe J; Morrell DS
Pediatr Dermatol; 2009; 26(4):405-8. PubMed ID: 19689514
[TBL] [Abstract][Full Text] [Related]
10. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: a case series of 16 patients.
Ross GL; Orchard DC
Australas J Dermatol; 2004 May; 45(2):100-2. PubMed ID: 15068455
[TBL] [Abstract][Full Text] [Related]
11. Parental satisfaction, efficacy, and adverse events in 54 patients treated with cantharidin for molluscum contagiosum infection.
Cathcart S; Coloe J; Morrell DS
Clin Pediatr (Phila); 2009 Mar; 48(2):161-5. PubMed ID: 18936288
[TBL] [Abstract][Full Text] [Related]
12. Beetle juice: a guide for the use of cantharidin in the treatment of molluscum contagiosum.
Moye V; Cathcart S; Burkhart CN; Morrell DS
Dermatol Ther; 2013; 26(6):445-51. PubMed ID: 24552407
[TBL] [Abstract][Full Text] [Related]
13. Cantharidin: a comprehensive review of the clinical literature.
Torbeck R; Pan M; DeMoll E; Levitt J
Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945640
[TBL] [Abstract][Full Text] [Related]
14. YCANTH
Gupta AK; Mann A; Vincent K; Abramovits W
Skinmed; 2023; 21(5):360-363. PubMed ID: 37945366
[TBL] [Abstract][Full Text] [Related]
15. Cantharidin Topical Solution 0.7%: First Approval.
Keam SJ
Paediatr Drugs; 2024 Jan; 26(1):95-100. PubMed ID: 38007409
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum.
Teixidó C; Díez O; Marsal JR; Giner-Soriano M; Pera H; Martinez M; Galindo-Ortego G; Schoenenberger JA; Real J; Cruz I; Morros R
Pediatr Dermatol; 2018 May; 35(3):336-342. PubMed ID: 29479727
[TBL] [Abstract][Full Text] [Related]
17. Safety of cantharidin: a retrospective review of cantharidin treatment in 405 children with molluscum contagiosum.
Moye VA; Cathcart S; Morrell DS
Pediatr Dermatol; 2014; 31(4):450-4. PubMed ID: 24383663
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of topical cantharidin and intralesional PPD to treat molluscum contagiosum.
Khattab FM; Nasr MM
J Dermatolog Treat; 2020 Dec; 31(8):850-854. PubMed ID: 31418621
[No Abstract] [Full Text] [Related]
19. Randomized placebo-controlled clinical trial on efficacy and safety of topical 10% Potassium hydroxide for
Giner-Soriano M; Teixidó C; Marsal JR; Díez O; Pera H; Vlacho B; Morros R;
J Dermatolog Treat; 2019 Dec; 30(8):750-756. PubMed ID: 30668179
[No Abstract] [Full Text] [Related]
20. Cantharidin in Dermatology.
Al-Dawsari NA; Masterpol KS
Skinmed; 2016; 14(2):111-4. PubMed ID: 27319954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
